D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Herc Holdings
HRI
$4.95B
| $4M | ﹤0.01% |
39,475
-34,162
| -46% | -$2.76M |
|
|
TETCU
1902
DELISTED
Tech and Energy Transition Corporation Unit
TETCU
| $4M | ﹤0.01% |
+400,000
| New | +$3.98M |
|
1903
PUT
AMC Entertainment Holdings
AMC
$2.38B
| $4M | ﹤0.01% |
39,130
+19,930
| +104% | +$1.52M |
|
|
VLD
1904
DELISTED
Velo3D, Inc.
VLD
| $3.99M | ﹤0.01% |
+11,126
| New | +$4.23M |
|
1905
DHI Group
DHX
$178M
| $3.99M | ﹤0.01% |
1,191,299
-111,179
| -9% | -$317K |
|
1906
CALL
Boston Beer
SAM
$1.93B
| $3.98M | ﹤0.01% |
3,300
-11,200
| -77% | -$11.7M |
|
1907
Sally Beauty Holdings
SBH
$1.48B
| $3.98M | ﹤0.01% |
197,696
-610,460
| -76% | -$10.2M |
|
|
RBAC
1908
DELISTED
RedBall Acquisition Corp.
RBAC
| $3.98M | ﹤0.01% |
+399,934
| New | +$4.22M |
|
1909
CALL
Vipshop
VIPS
$7.13B
| $3.97M | ﹤0.01% |
+133,100
| New | +$4.59M |
|
1910
CALL
Cintas
CTAS
$86B
| $3.96M | ﹤0.01% |
46,400
| – | – |
|
1911
PUT
Elastic
ESTC
$6.46B
| $3.95M | ﹤0.01% |
35,500
-40,400
| -53% | -$5.74M |
|
|
CSGS
1912
DELISTED
CSG Systems International
CSGS
| $3.94M | ﹤0.01% |
87,779
-57,197
| -39% | -$2.64M |
|
1913
Coherus Oncology
CHRS
$222M
| $3.94M | ﹤0.01% |
269,633
-13,937
| -5% | -$237K |
|
1914
WisdomTree
WT
$2.97B
| $3.94M | ﹤0.01% |
629,905
-416,747
| -40% | -$2.39M |
|
|
CMBT
1915
CMB.TECH NV
CMBT
$4.47B
| $3.91M | ﹤0.01% |
+427,177
| New | +$3.77M |
|
1916
JELD-WEN Holding
JELD
$98.2M
| $3.9M | ﹤0.01% |
140,970
-23,587
| -14% | -$655K |
|
1917
PUT
Bausch Health
BHC
$1.69B
| $3.9M | ﹤0.01% |
122,900
-83,300
| -40% | -$2.44M |
|
1918
Tronox
TROX
$981M
| $3.9M | ﹤0.01% |
213,136
-249,659
| -54% | -$4.36M |
|
|
APGB.U
1919
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
| $3.9M | ﹤0.01% |
+390,733
| New | +$4.02M |
|
1920
CALL
Vroom Inc
VRM
$36.8M
| $3.9M | ﹤0.01% |
+1,250
| New | +$4.05M |
|
|
VNE
1921
DELISTED
Veoneer, Inc.
VNE
| $3.9M | ﹤0.01% |
159,164
+86,884
| +120% | +$2.27M |
|
|
UMPQ
1922
DELISTED
Umpqua Holdings Corp
UMPQ
| $3.88M | ﹤0.01% |
221,251
+169,618
| +329% | +$2.87M |
|
1923
Scholastic
SCHL
$766M
| $3.88M | ﹤0.01% |
128,745
-26,151
| -17% | -$736K |
|
1924
Mueller Water Products
MWA
$4.05B
| $3.87M | ﹤0.01% |
278,936
-95,697
| -26% | -$1.24M |
|
|
SNBR
1925
CALL
DELISTED
Sleep Number
SNBR
| $3.87M | ﹤0.01% |
27,000
+8,200
| +44% | +$984K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.